Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.13
+0.30 (4.39%)
At close: Dec 5, 2025, 4:00 PM EST
7.17
+0.04 (0.56%)
After-hours: Dec 5, 2025, 6:54 PM EST
ARCT Stock Forecast
ARCT's stock price has decreased by -58.59% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ARCT stock have an average target of 38.67, with a low estimate of 9.00 and a high estimate of 72. The average target predicts an increase of 442.36% from the current stock price of 7.13.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ARCT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $12 → $9 | Hold | Maintains | $12 → $9 | +26.23% | Nov 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $72 | Buy | Maintains | $140 → $72 | +909.82% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $9 | Hold | Maintains | $12 → $9 | +26.23% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $60 → $12 | Strong Buy → Hold | Downgrades | $60 → $12 | +68.30% | Oct 24, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $49 → $12 | Strong Buy → Hold | Downgrades | $49 → $12 | +68.30% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
92.55M
from 152.31M
Decreased by -39.24%
Revenue Next Year
83.86M
from 92.55M
Decreased by -9.38%
EPS This Year
-2.06
from -3.00
EPS Next Year
-3.20
from -2.06
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 109.5M | 182.6M | ||||
| Avg | 92.5M | 83.9M | ||||
| Low | 73.3M | 29.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -28.1% | 97.3% | ||||
| Avg | -39.2% | -9.4% | ||||
| Low | -51.9% | -67.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.56 | -1.30 | ||||
| Avg | -2.06 | -3.20 | ||||
| Low | -2.59 | -4.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.